Susan Hasty, Publisher
Table of Contents . . . October 7th, 1996Non-Subscriber - Summaries Only
Conference Coverage (ICAAC) - Candidate HBV Agent Lobucavir Discussed at Meeting
HAV/HBV Vaccines - Hepatitis A+B Twinrix Vaccine Receives European Approval
Immunology (HBV) - Cytokine mRNA Differs in Hepatitis B and Biliary Cirrhosis
Mutagenesis (HBV) - Researchers Shed Light on Hepatitis B Mutation Preference
Therapy (HBV) - IFN-(alpha) Does Not Promote Autoantibody Development
Therapy (HCV) - IFN-(alpha) is Useful in HIV Infected Patients with CD4+ >200
At-Risk Populations - "Risk of Exposition to Viral Hepatitis E For Travellers to Mexico."
Epidemiology (HBV) - "Prevalence of Hepatitis B Virus Markers in 1,200 Canadian Children 8-10 Years-Old."
Epidemiology (Hepatitis) - "Critical Issues in the Epidemiology of Hepatitis C and G."
Pathogenesis (HCV) - "Molecular Targets in Hepatitis C Virus."
Diagnostics (HCV) - "Second-Generation Line Probe Assay for Hepatitis C Virus Genotyping."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.